...

🏥 Emergency Cardiac Assessment Tool

HEART Score Calculator — Chest Pain Risk Stratification

The HEART Score is the most widely validated clinical tool for risk-stratifying patients with chest pain in the emergency department. Used by emergency physicians and cardiologists worldwide, it predicts the 6-week risk of Major Adverse Cardiac Events (MACE) — including myocardial infarction, cardiac death, and urgent revascularisation — using five objective clinical parameters.

This calculator applies the original Six et al. (2008) scoring criteria, validated in over 40,000 patients and endorsed by the 2022 ACC Expert Consensus Decision Pathway. Select the criteria that apply to your patient to get an instant HEART score, risk category, and clinical interpretation.

✅ Original Six 2008 criteria ✅ 40,000+ patient validation ✅ 6-week MACE risk % ✅ Low / Intermediate / High risk ✅ Clinical pathway guidance ✅ 2022 ACC endorsed

❤️ HEART Score Calculator

Click one option in each section. Your HEART Score and risk level update automatically as you make selections.

H

History — Clinical suspicion of ACS

Assess symptoms: chest pressure, radiation to arm/jaw, diaphoresis, exertional onset, relief with nitrates.

E

ECG — Electrocardiogram findings

Score 2 only for ST deviation NOT attributable to LBBB, LVH, or digoxin effect.

A

Age — Patient’s age at presentation

Older age is an independent predictor of adverse cardiac events.

R

Risk Factors — Known cardiovascular risk factors

Includes: hypertension, hypercholesterolaemia, diabetes, obesity (BMI >30), current/recent smoker, family history of CAD. Known atherosclerotic disease = score 2 directly.

T

Troponin — Level relative to upper reference limit (URL)

Use your institution’s troponin assay 99th percentile URL. High-sensitivity troponin (hsTnI/hsTnT) is now standard.

0
/ 10

History
ECG
Age
Risk Factors
Troponin

📌 At a Glance

The HEART Score is scored 0–10 across five components: History, ECG, Age, Risk Factors, and Troponin. A score of 0–3 = low risk (6-week MACE ~1.7%), 4–6 = intermediate risk (~16.6%), and 7–10 = high risk (~65%). It has been validated in over 40,000 patients and is endorsed by the 2022 ACC Expert Consensus Decision Pathway.

What Is the HEART Score and Why Does It Matter?

Chest pain is one of the most common and most challenging presentations in emergency medicine. Every year, millions of patients arrive at emergency departments worldwide with chest pain. The vast majority — more than 80% — do not have an acute coronary syndrome (ACS). Yet the consequences of missing the minority who do have ACS are catastrophic: myocardial infarction, cardiac arrest, and death. This clinical dilemma — accurately separating the small high-risk group from the large low-risk majority — is precisely the problem the HEART Score was designed to solve.

Developed by Barbra Six and colleagues in the Netherlands and published in the Netherlands Heart Journal in 2008, the HEART Score provides a structured, reproducible framework for risk-stratifying patients with chest pain using five clinical parameters that every emergency physician can quickly assess: the patient's history, the ECG, their age, their cardiovascular risk factors, and their troponin level. Each component is scored 0, 1, or 2 points, giving a maximum total of 10. The total score places the patient into one of three risk categories, each with well-defined clinical implications.

Before the HEART Score, chest pain management was largely based on clinical gestalt — experienced clinicians making intuitive judgements about who needed admission. The problem was that intuition varied enormously between clinicians, and a significant proportion of genuinely low-risk patients were admitted unnecessarily, driving up costs and hospital bed pressures. The HEART Score provides an objective, evidence-based alternative that has been shown in prospective trials to safely reduce unnecessary admissions by approximately 20% without increasing adverse events.

HEART Score Interpretation — The Three Risk Categories

0 – 3

🟢 Low Risk

6-week MACE: ~0.9% – 1.7%

NPV ~99%. Consider early discharge with outpatient follow-up. Apply the HEART Pathway (serial troponins at 0h & 3h) before discharge. Routine admission is not required for uncomplicated low-risk presentations.

4 – 6

🟡 Intermediate Risk

6-week MACE: ~12% – 16.6%

Admission to observation unit. Serial troponins (0h, 3h, 6h). Non-invasive testing before discharge — exercise stress test, CT coronary angiography, or nuclear imaging. Cardiology consultation recommended.

7 – 10

🔴 High Risk

6-week MACE: ~50% – 65%

Immediate cardiology consultation and hospital admission. Early invasive strategy — coronary angiography is typically indicated. Anti-platelet and anticoagulation therapy as per ACS protocols. Do not discharge.

⚠️ Important: A HEART Score is not a replacement for clinical judgement. Even a low HEART Score does not rule out ACS with absolute certainty. Apply the score alongside full clinical assessment, serial troponins per your institution's protocol, and cardiology input when in doubt. Alternative life-threatening diagnoses (pulmonary embolism, aortic dissection) must be considered independently.

The 5 HEART Score Components Explained in Detail

H

History — Clinical Suspicion of ACS (0, 1, or 2 points)

The History component assesses how closely the patient's presenting symptoms match a classic ACS presentation. Score 0 (slightly suspicious) for atypical symptoms like sharp or positional chest pain, or symptoms more consistent with a musculoskeletal or gastrointestinal cause. Score 1 (moderately suspicious) when there are some ACS features but the picture is mixed. Score 2 (highly suspicious) for classic presentations: retrosternal pressure, radiation to the jaw or left arm, diaphoresis, onset with exertion, or relief with nitrates. This component is the most subjective — studies show up to 70% discordance between emergency physicians and cardiologists. The general rule is: when in doubt, score higher.

E

ECG — Electrocardiogram Findings (0, 1, or 2 points)

Score 0 for a completely normal ECG. Score 1 for non-specific repolarisation disturbances — this includes LBBB, LVH with strain pattern, paced rhythm, digoxin effect, or any ST changes attributable to a known non-ischaemic cause. Score 2 for significant ST deviation that is not explained by LBBB, LVH, or digoxin effect. Critically, a LBBB or LVH pattern that mimics ST elevation does NOT score 2 — it scores 1, because the ST change is not directly indicative of ischaemia. This distinction is clinically important and a common source of error in HEART Score calculation.

A

Age — Patient's Age at Presentation (0, 1, or 2 points)

Score 0 for age under 45 years. Score 1 for ages 45–64. Score 2 for age 65 and above. Age is one of the strongest independent predictors of cardiovascular risk and ACS. Older patients not only have higher baseline ACS rates but also more frequently present atypically — without chest pain, with dyspnoea, diaphoresis, or fatigue as the predominant symptom — making clinical diagnosis more challenging. The age thresholds in the HEART Score are based on the epidemiological distribution of ACS risk across age groups in the original validation cohort.

R

Risk Factors — Cardiovascular Risk Factor Burden (0, 1, or 2 points)

Score 0 if the patient has no known cardiovascular risk factors. Score 1 if they have one or two of the following: hypertension, hypercholesterolaemia, diabetes mellitus, obesity (BMI >30), current or recent smoker (within 90 days), or a positive family history of coronary artery disease (first-degree relative under 65 for women, under 55 for men). Score 2 if three or more risk factors are present, OR if the patient has any known atherosclerotic disease — including history of coronary artery disease, previous MI, previous coronary intervention (PCI/CABG), stroke, or peripheral arterial disease. Known atherosclerotic disease automatically scores 2, regardless of the number of conventional risk factors.

T

Troponin — Cardiac Biomarker Level Relative to Upper Reference Limit (0, 1, or 2 points)

Score 0 if troponin is at or below the normal upper reference limit (URL) — the 99th percentile of your institution's specific assay. Score 1 if troponin is 1–3 times the URL. Score 2 if troponin exceeds 3 times the URL. The troponin assay type and its specific URL vary between institutions — always use your local laboratory's reference range. With the widespread adoption of high-sensitivity troponin (hsTnI or hsTnT) assays, the URL thresholds are lower than with conventional assays, meaning more patients will have troponin detected. If troponin is elevated despite a low HEART Score (<4), most guidelines still recommend further evaluation before discharge.

HEART Score vs TIMI Score vs GRACE Score — Which to Use?

Emergency physicians have several scoring systems available for chest pain and ACS risk stratification. Understanding when to use each prevents misapplication of these tools:

Best for: ED Chest Pain Triage

HEART Score

Specifically designed for undifferentiated chest pain in the ED. Excellent for identifying low-risk patients who can be safely discharged. Validated in 40,000+ patients. 2022 ACC endorsed. Use for: all adult ED chest pain patients without confirmed STEMI.

Best for: Confirmed NSTEMI/UA

TIMI Score

Designed for patients already diagnosed with NSTEMI or unstable angina. NOT designed for undifferentiated chest pain. Tends to classify more patients as intermediate risk, leading to higher unnecessary admission rates when applied to undifferentiated chest pain.

Best for: In-hospital ACS Prognosis

GRACE Score

Designed for in-hospital risk stratification in confirmed ACS. Predicts in-hospital and 6-month mortality. More complex (8 variables) and better suited for post-diagnosis management decisions than initial ED triage. Requires specific variables like Killip class.

Newer alternative

EDACS Score

Emergency Department Assessment of Chest Pain Score — a newer alternative specifically designed for use with high-sensitivity troponin assays. Used by some centres as an alternative or complementary tool to HEART. Less validated globally than HEART but gaining traction.

💡 Key principle: The HEART Score and TIMI Score answer different clinical questions. HEART asks: "Does this chest pain patient need admission?" TIMI asks: "Given this patient has ACS, how aggressively should I treat them?" Using TIMI for ED triage of undifferentiated chest pain systematically over-classifies risk and leads to unnecessary admissions.

The HEART Pathway — Combining the Score with Serial Troponins

The HEART Pathway is an enhanced version of the HEART Score that incorporates serial high-sensitivity troponin measurements to maximise the safety of early discharge. Published in the Annals of Emergency Medicine, the HEART Pathway adds troponin testing at 0 hours and 3 hours to the standard HEART Score assessment.

For patients with a HEART Score of 0–3 AND two consecutively negative high-sensitivity troponin measurements (at 0h and 3h), the 6-week MACE rate drops to below 1%, with a negative predictive value approaching 99.5%. This combination supports the safe discharge of approximately 20% more patients from the ED compared to standard care, without any significant increase in adverse outcomes — a finding confirmed by a randomised controlled trial.

The practical implementation of the HEART Pathway in your institution requires alignment of the troponin assay's specific URL, serial testing intervals, and clear nursing protocols for repeat measurements. The pathway works best when it is embedded into institutional chest pain protocols rather than applied ad hoc by individual clinicians.

Factors That Influence HEART Score Accuracy

FactorEffect on AccuracyClinical Note
History subjectivityReduces inter-rater reliabilityUp to 70% discordance between EPs and cardiologists; when in doubt, score higher
High-sensitivity troponin assayImproves sensitivityhsTnI/hsTnT detect more minor elevations; redefines the URL threshold
Early presentationTroponin may be negativeTroponin may not rise until 3–6h after symptom onset; serial testing is essential
Atypical ACS presentationMay underestimate riskWomen, elderly, and diabetics more often present atypically; consider upscoring History
Renal failureChronically elevated troponinBaseline troponin may be above URL without acute myocardial injury; compare to prior values
Non-ACS troponin elevationFalse-positive T scoreMyocarditis, PE, sepsis, and COPD exacerbation can raise troponin; clinical context essential
LBBB / paced rhythmLimits ECG interpretationScore E as 1 (non-specific), not 2, unless baseline ECG confirms new change

Who Should NOT Have a HEART Score Calculated?

The HEART Score was specifically developed and validated for patients presenting to the ED with undifferentiated chest pain who are being evaluated for possible ACS. There are important scenarios where the score should not be applied or should be applied with significant caution:

Do NOT use HEART Score for: Patients with confirmed STEMI on ECG (these patients require immediate reperfusion — do not delay with risk scoring); patients with haemodynamic instability requiring immediate intervention; chest pain with a clearly identified non-cardiac cause (e.g., confirmed pneumothorax, rib fracture on imaging); paediatric patients under 18 years. For patients with confirmed NSTEMI, use the GRACE Score for in-hospital risk stratification instead.

Use with caution for: Patients with end-stage renal disease (chronically elevated troponin confounds the T score); patients with active myocarditis or other known causes of troponin elevation; patients who are unable to provide a reliable history.

Frequently Asked Questions About the HEART Score

What is the HEART Score?
The HEART Score is a validated clinical risk stratification tool developed in 2008 by Six and colleagues for use in emergency departments. It predicts the 6-week risk of Major Adverse Cardiac Events (MACE) — including cardiac death, myocardial infarction, and urgent revascularisation — in patients presenting with chest pain. The score ranges from 0 to 10 and is calculated using five components: History, ECG, Age, Risk factors, and Troponin.
What does each HEART Score range mean clinically?
A HEART Score of 0–3 indicates low risk with a 6-week MACE probability of approximately 0.9–1.7%. These patients may be considered for early discharge with outpatient follow-up (especially if serial troponins are negative). A score of 4–6 indicates intermediate risk (~12–16.6% MACE) requiring observation and further testing before a discharge decision. A score of 7–10 indicates high risk (~50–65% MACE) requiring immediate cardiology consultation and admission for early invasive evaluation.
What is the HEART Pathway?
The HEART Pathway combines the HEART Score with serial high-sensitivity troponin measurements at 0 hours and 3 hours. Patients with a HEART Score of 0–3 AND two consecutive negative troponins can be discharged with very high safety (NPV ~99.5%). A randomised controlled trial showed the HEART Pathway reduced admissions by approximately 20% versus standard care without increasing adverse events. It requires clear institutional protocols to implement safely.
How accurate is the HEART Score?
The HEART Score has been validated in over 40,000 patients across multiple international prospective studies. It achieves a negative predictive value of approximately 99% for the low-risk category (scores 0–3), and has been independently validated in Europe, North America, and Australia. It is endorsed by the 2022 ACC Expert Consensus Decision Pathway for chest pain evaluation in the ED. However, no score is 100% accurate, and clinical judgement remains essential.
What are the limitations of the HEART Score?
Key limitations include: the History component is subjective with high inter-rater variability; it does not recognise STEMI (which requires separate management); it does not exclude alternative diagnoses like pulmonary embolism or aortic dissection; troponin interpretation can be confounded by renal failure, myocarditis, or other non-ACS causes; and accuracy may vary in populations different from the original validation cohort. Always use the score as a tool to support, not replace, comprehensive clinical assessment.
How does HEART Score differ from the TIMI Score?
The HEART Score was designed for undifferentiated chest pain in the ED — its primary purpose is to identify low-risk patients who can be safely discharged. The TIMI Score was designed for patients already diagnosed with NSTEMI or unstable angina. Studies show HEART Score identifies significantly more low-risk patients than TIMI, making it more effective for reducing unnecessary admissions. TIMI systematically over-classifies undifferentiated chest pain patients as intermediate or high risk.
Can I use the HEART Score for patients with renal failure?
Use with significant caution. Patients with chronic kidney disease and especially end-stage renal disease often have chronically elevated troponin levels above the standard URL, which does not represent acute myocardial injury. In these patients, compare the current troponin against a baseline value. A rising or falling troponin pattern (delta troponin) is more diagnostically meaningful than a single elevated reading. The HEART Score may over-estimate risk in patients with chronically elevated troponin.

Related Cardiac & Health Calculators

Use these free tools for a comprehensive cardiac risk and health assessment.

Medical Disclaimer: The HEART Score Calculator is intended for use by qualified healthcare professionals as a clinical decision support tool only. It is not designed for patient self-assessment. A HEART Score does not diagnose or exclude acute coronary syndrome, and a low score does not guarantee the absence of cardiac disease. Always apply the score within the full context of clinical assessment, serial troponin testing per institutional protocol, ECG interpretation, and relevant diagnostic imaging. This tool does not replace the clinical judgement of a qualified physician. If you are experiencing chest pain, call emergency services immediately.
Scroll to Top
Seraphinite AcceleratorOptimized by Seraphinite Accelerator
Turns on site high speed to be attractive for people and search engines.